Rapport Therapeutics, Inc. (NASDAQ:RAPP – Get Free Report) CEO Abraham Ceesay sold 2,210 shares of the stock in a transaction on Wednesday, September 23rd. The shares were sold at an average price of $39.17, for a total transaction of $86,565.70. Following the sale, the chief executive officer directly owned 456,767 shares of the company’s stock, […]
Rapport Therapeutics (NASDAQ:RAPP) CEO Abraham Ceesay Sells 2,210 Shares of Stock
